Sesame Summit 2026 – application open

Spiich Labs raises €600k pre-seed for AI healthcare platform

European healthcare AI is experiencing a renaissance, driven by regulatory clarity from the AI Act and growing corporate adoption. Spiich Labs, a Stockholm-based startup developing AI-powered speech analysis for healthcare diagnostics, has secured €600k in pre-seed funding led by Tandem Health, with participation from Creandum founders and Ampli Ventures.

The funding represents a strategic bet on the intersection of voice technology and healthcare, where European startups are carving out distinctive advantages through privacy-first approaches and regulatory compliance.

AI healthcare funding attracts Nordic investors

Tandem Health’s lead investment reflects the Swedish fund’s thesis around digital health infrastructure that can scale across fragmented European markets. The participation of Creandum founders signals strong conviction from operators who previously backed Spotify and Klarna through similar early-stage dynamics.

“Speech analysis represents an untapped diagnostic frontier where European companies can lead globally,” noted a Tandem Health partner. “Spiich’s approach to privacy-preserving voice biomarkers aligns perfectly with European regulatory frameworks whilst addressing genuine clinical needs.”

The investor mix combines healthcare-focused capital with generalist expertise, providing Spiich with both sector knowledge and scaling playbooks from Nordic success stories. Ampli Ventures’ involvement adds operational depth to the round.

Voice biomarkers target European healthcare systems

Spiich Labs is developing AI algorithms that analyse speech patterns to detect early indicators of neurological and respiratory conditions. The platform processes vocal biomarkers through machine learning models trained on European datasets, ensuring compliance with GDPR whilst building clinically relevant insights.

The startup’s go-to-market strategy focuses initially on Nordic healthcare systems, where digital health adoption rates exceed European averages and procurement processes favour innovative solutions. Early pilots with Swedish hospitals have demonstrated diagnostic accuracy improvements of 15-20% for certain respiratory conditions.

“European healthcare systems need diagnostic tools that integrate seamlessly with existing workflows whilst maintaining patient privacy,” explained the Spiich Labs CEO. “Our voice analysis platform delivers clinical insights without storing personal data, addressing two critical healthcare challenges simultaneously.”

Funding will accelerate product development and support expansion across the Nordics, with plans for broader European deployment by 2026. The company competes with US-based voice AI startups but differentiates through European regulatory compliance and healthcare system integration.

This funding positions Spiich within Europe’s growing voice technology ecosystem, where regulatory advantages and healthcare market access create defensible competitive moats. The pre-seed validates European investors’ appetite for AI healthcare solutions that leverage continental strengths.

you might also like

Fundraising 23 seconds ago

Europe’s healthcare technology sector continues its momentum with patient access platforms emerging as a critical bridge between pharmaceutical innovation and real-world medical need. As regulatory frameworks evolve and drug approval timelines remain lengthy, companies facilitating early access to treatments are attracting significant investor attention across European markets. myTomorrows, the Amsterdam-based patient access platform, has secured €25 million in growth equity financing to expand its mission of connecting patients with investigational treatments. The funding round was led by Avego, with participation from existing investors, marking a significant milestone in European digital health investment activity. Patient access funding attracts European growth investors The investment from Avego reflects growing institutional confidence in the patient access sector, particularly within Europe’s increasingly sophisticated healthcare technology ecosystem. Unlike traditional pharma services companies, myTomorrows operates at the intersection of regulatory expertise and digital infrastructure, positioning itself as essential infrastructure for pharmaceutical companies navigating complex global access requirements. “Patient access represents one of healthcare’s most pressing challenges, with millions waiting for approved therapies while promising treatments remain trapped in development pipelines,” noted the lead investor. The timing aligns with heightened regulatory focus on expanded access programmes across European Union markets, where national health systems are increasingly supportive of structured early access initiatives. The investor composition suggests confidence in myTomorrows’ European market positioning, with growth equity backing indicating the platform has achieved meaningful scale metrics. For Avego, this represents a strategic bet on healthcare infrastructure plays that benefit from regulatory tailwinds rather than fighting against compliance complexity. Global expansion strategy leverages European regulatory expertise myTomorrows’ approach differentiates itself by combining pharmaceutical industry expertise with patient-centric technology, creating what founder and CEO Michel van Houten describes as “a bridge between innovation and access that works within existing regulatory frameworks rather than attempting to disrupt them.” This positioning proves particularly valuable in European markets, where medical device regulations and pharmaceutical oversight require nuanced navigation. The €25 million injection will fuel international expansion, with particular emphasis on strengthening operations across key European healthcare markets including Germany, France, and the United Kingdom. Unlike many healthcare technology companies that struggle with fragmented European compliance requirements, myTomorrows benefits from regulatory complexity, as pharmaceutical companies increasingly seek specialised partners for multi-jurisdiction access programmes. “We’re seeing unprecedented demand from both pharmaceutical partners and healthcare providers for structured patient access solutions,” van Houten explained. “European regulatory frameworks are evolving to support earlier patient access, creating a significant opportunity for platforms that can navigate these systems effectively.” The funding positions myTomorrows advantageously against competitors in the patient access space, many of which remain focused on single-market solutions or lack the regulatory expertise required for complex multi-national programmes. With European pharmaceutical companies increasingly prioritising patient access as a competitive differentiator, specialised platforms like myTomorrows are becoming essential infrastructure rather than optional services. This funding round signals broader institutional recognition of patient access as a critical healthcare infrastructure layer, with European investors demonstrating appetite for companies that solve regulatory complexity rather than attempt to circumvent it. For myTomorrows, the capital provides runway to capture growing demand while European healthcare systems increasingly embrace structured early access programmes.

Fundraising 7 minutes ago

The social commerce revolution is reshaping how European consumers discover and purchase products, with artificial intelligence emerging as the critical differentiator for platforms seeking to convert social engagement into revenue. This shift has captured the attention of forward-thinking venture capital, particularly as traditional e-commerce growth plateaus across European markets. Paris-based Paage has secured €2M in seed funding to accelerate development of its AI-powered social commerce platform, positioning itself at the intersection of artificial intelligence and social shopping trends sweeping across Europe. The round was led by Aglaé Ventures, with participation from Kima Ventures and Cassius, reflecting growing investor confidence in AI-driven commerce solutions. Strategic investors back social commerce AI vision Aglaé Ventures’ decision to lead this round signals their commitment to backing European AI startups that can compete on a global scale. The firm, known for its early-stage technology investments, sees Paage’s approach to combining artificial intelligence with social commerce as addressing a critical gap in the current market landscape. Kima Ventures, with its extensive portfolio of over 1,000 startups, brings valuable cross-pollination opportunities from their network of social media and e-commerce companies. Cassius rounds out the investor group with their focus on consumer technology platforms. This investor combination provides Paage with both capital and strategic guidance across AI development, social platform integration, and consumer behaviour analytics. The funding comes at a pivotal moment when European retailers are increasingly seeking sophisticated tools to navigate the complex social commerce ecosystem, where traditional advertising models are proving insufficient for driving meaningful engagement and conversion. AI cockpit addresses European market fragmentation Paage’s “AI cockpit” approach acknowledges the unique challenges facing European social commerce operators. Unlike the more homogeneous US market, European businesses must navigate diverse languages, cultural preferences, and regulatory frameworks across multiple countries simultaneously. The platform’s artificial intelligence engine is designed to optimise social commerce campaigns across different European markets, automatically adjusting messaging, timing, and channel selection based on local consumer behaviour patterns. This addresses a persistent pain point for European brands attempting to scale their social commerce operations beyond their home markets. The company plans to utilise the funding primarily for expanding its AI capabilities and building integrations with major European social platforms and e-commerce systems. With GDPR compliance built into its core architecture, Paage positions itself as a privacy-first alternative to US-based social commerce tools. This funding round reflects the broader maturation of European AI startups, moving beyond purely research-focused ventures toward practical applications that can compete with Silicon Valley counterparts while addressing uniquely European market dynamics.

Fundraising 10 minutes ago

Europe’s private education sector stands at an inflection point. While digital transformation has swept through every other industry, educational institutions remain anchored to legacy systems that frustrate administrators, teachers, and parents alike. This persistent inefficiency has created a €2.8 billion market opportunity that French startup Filiz is determined to capture, having just secured €6 million in Series A funding led by Hexa to accelerate its mission across European markets. The funding represents a significant validation of Filiz’s approach to solving one of education’s most entrenched problems: the fragmented, manual processes that plague school administration. Founded in 2020, the Paris-based company has developed a comprehensive platform that digitises everything from student records and timetabling to parent communication and financial management. Series A funding validates European EdTech consolidation Hexa’s investment thesis centres on the structural advantages European EdTech companies enjoy over their Silicon Valley counterparts. “European schools operate under strict data protection frameworks that American solutions simply cannot navigate,” explains Hexa Partner Marie Dubois. “Filiz has built GDPR compliance into its core architecture from day one, giving it an unassailable competitive moat.” The timing proves strategic. Europe’s private education sector has accelerated digital adoption by five years following the pandemic, yet most institutions still rely on disparate systems that require manual integration. This fragmentation creates operational inefficiencies that Filiz’s unified platform directly addresses. Beyond Hexa’s lead investment, the round attracted participation from several unnamed strategic investors, suggesting broader industry validation. The €6 million raise positions Filiz among the larger EdTech funding rounds in Europe this year, trailing only Germany’s Zavvy (€10M) and Sweden’s Mentimeter’s expansion round. Platform approach tackles European market fragmentation Filiz’s product strategy reflects deep understanding of European educational diversity. Rather than imposing a one-size-fits-all solution, the platform adapts to different national curricula, language requirements, and regulatory frameworks across its target markets of France, Germany, and the Benelux region. “We’re not trying to americanise European education,” states Filiz CEO and co-founder Thomas Laurent. “Our platform respects the pedagogical traditions and regulatory requirements that make each European market unique, while eliminating the administrative burden that prevents schools from focusing on teaching.” The company’s traction metrics validate this approach. Filiz currently serves over 150 private schools across France, with average contract values of €12,000 annually. Client retention rates exceed 95%, and the platform has processed over €50 million in school fee transactions since launch. The Series A funding will primarily fuel international expansion, with Germany identified as the priority market. Filiz plans to establish a Berlin office by Q2 2025 and hire 15 additional engineers to support localisation efforts. The company also intends to expand its product suite with AI-powered analytics tools that provide schools with actionable insights on student performance and operational efficiency. This funding signals growing investor confidence in European EdTech’s ability to compete globally while serving distinctly European needs. As regulatory complexity continues to favour locally-built solutions, Filiz appears well-positioned to capture the digital transformation wave sweeping through Europe’s €180 billion education sector.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.